WeVote
Log In

Bill

Bill

SB 2378

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

89th Legislature (2025) Introduced by Kelly Hancock

Texas must report on state opioid antagonist programs' scope, effectiveness, and coordination to inform overdose prevention policy and resource allocation decisions.

Referred to Health & Human Services
#alcoholism&drugabuse(i0030) #crimes--drugs(i0185) #education--higher--institutions&programs(i0223) #health&humanservicescommission(v0177) #stateagencies #boards&commissions(i0749)
0
WeVote Research Nonpartisan
Bill Summary · SB 2378

Legislative bill overview

SB 2378 requires the Texas government to produce a comprehensive report on existing opioid antagonist programs (medications like naloxone that reverse overdoses). The bill directs state agencies to document current programs, their effectiveness, and how they work to prevent and reverse opioid overdoses across Texas.

Why is this important

Opioid overdose deaths remain a significant public health crisis in Texas and nationally. A systematic report on antagonist programs would provide lawmakers and public health officials with data-driven information to identify gaps, improve coordination between programs, and potentially expand life-saving interventions to underserved areas.

Potential points of contention

  • Cost and implementation: Developing and maintaining comprehensive reporting systems requires state resources and staff time that could be directed elsewhere
  • Program scope definition: Disagreement may arise over which programs should be included in the report and how to measure their effectiveness consistently
  • Privacy concerns: Collecting data on opioid antagonist use and distribution could raise questions about privacy protections for individuals and healthcare providers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.